MFIM
ALDX icon

Mesirow Financial Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History

Mesirow Financial Investment Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,711
Closed -$195K – 81
2021
Q4 		$195K Hold
48,711
– – 0.56% 70
2021
Q3 		$428K Sell
48,711
-1,351
-3% -$12.4K 1.26% 44
2021
Q2 		$567K Sell
50,062
-13,572
-21% -$163K 1.45% 24
2021
Q1 		$756K Sell
63,634
-1,064
-2% -$12.3K 2.06% 3
2020
Q4 		$444K Buy
64,698
+307
+0.5% +$2.16K 1.4% 26
2020
Q3 		$477K Sell
64,391
-27,175
-30% -$176K 2.04% 3
2020
Q2 		$382K Sell
91,566
-2,297
-2% -$8.39K 1.8% 10
2020
Q1 		$232K Buy
93,863
+27,014
+40% +$122K 1.46% 45
2019
Q4 		$388K Sell
66,849
-2,180
-3% -$12.6K 1.64% 29
2019
Q3 		$364K Buy
69,029
+6,293
+10% +$33.9K 1.53% 39
2019
Q2 		$373K Buy
62,736
+6,775
+12% +$51K 1.36% 47
2019
Q1 		$505K Buy
55,961
+17,864
+47% +$152K 2.01% 16
2018
Q4 		$316K Hold
38,097
– – 2.04% 19
2018
Q3 		$526K Sell
38,097
-3,031
-7% -$24.6K 2.71% 4
2018
Q2 		$327K Buy
+41,128
New +$328K 1.45% 40

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mesirow Financial Investment Management's ALDX Position: Q1 2022 in Review

Mesirow Financial Investment Management sold out of Aldeyra Therapeutics (ALDX) in Q1 2022, closing a stake of 48,711 shares — an estimated $195K sold.

Mesirow Financial Investment Management first reported a position in ALDX in Q2 2018 and held it in 15 quarters. The position peaked at $756K in Q1 2021. 111 funds tracked by Wall St. Rank hold ALDX as of Q1 2022.

  • Mesirow Financial Investment Management reported no remaining Aldeyra Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 48,711 Aldeyra Therapeutics shares in Q1 2022, an estimated $195K.
  • Mesirow Financial Investment Management first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 15 quarters.
  • Mesirow Financial Investment Management's Aldeyra Therapeutics position peaked at $756K in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2022.

Based on Mesirow Financial Investment Management's 13F filing for Q1 2022, filed 2 May 2022.